
Academic Journal
Q1European Journal of Endocrinology
About European Journal of Endocrinology
European Journal of Endocrinology is a scholarly journal published by Oxford University Press. SCImago 2025 places it in Q1 with an SJR of 2.02 and an H-index of 185.
Its listed coverage is 1960, 1979, 1994-2026 and its research categories include Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medicine (miscellaneous) (Q1). The 2025 dataset reports 268 documents and 3269 citations across the latest three-year reporting window.
The scope of the European Journal of Endocrinology is vast and covers all areas of endocrinology, with a special focus on research that contributes to the understanding and treatment of endocrine diseases. The journal is committed to publishing high-quality studies that bridge the gap between basic research and clinical practice.
Key areas covered by the journal include:
-
Metabolic Disorders and Diabetes: Research on metabolic syndrome, obesity, type 1 and type 2 diabetes, and their management is a key focus of EJE. The journal publishes studies exploring the molecular mechanisms of these conditions, novel therapeutic strategies, and clinical management.
-
Thyroid Diseases: The journal frequently publishes studies on thyroid function, thyroid cancer, and autoimmune thyroid diseases. Research exploring thyroid hormone signaling, the regulation of thyroid function, and the clinical management of thyroid disorders is regularly featured.
-
Reproductive Endocrinology: Another significant area of interest for EJE is reproductive endocrinology. The journal publishes research on menstrual disorders, polycystic ovary syndrome (PCOS), infertility, and menopause. Research in this area contributes to improving reproductive health and treatment outcomes.
-
Adrenal Disorders: EJE includes research on adrenal glands, including conditions like Cushing’s syndrome, adrenal insufficiency, and hyperaldosteronism. These studies are essential for understanding adrenal diseases and improving patient care.
-
Bone Metabolism and Osteoporosis: EJE publishes studies on bone metabolism, osteoporosis, and the role of hormones in bone health. Articles explore the mechanisms of bone loss, the impact of hormonal changes on bone density, and the latest treatments for osteoporosis.
-
Endocrine Neoplasia: The journal also covers endocrine cancers, including research on the genetics, pathophysiology, and treatment options for endocrine tumors such as pituitary adenomas, thyroid carcinoma, and adrenal tumors.
-
Endocrine Regulation and Hormone Action: Basic research on the regulation of hormone secretion, hormone receptors, and signaling pathways is a critical area of focus. This includes studies on the molecular and cellular mechanisms that regulate hormone function and their impact on health.
By focusing on these diverse aspects of endocrinology, EJE provides a platform for researchers to share their findings on cutting-edge advancements in endocrine science. The journal’s comprehensive scope ensures it remains a vital resource for clinicians and researchers working to improve patient care and advance the field of endocrinology.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The European Journal of Endocrinology (EJE) is an esteemed international journal that publishes groundbreaking research on all aspects of endocrinology. Founded by the European Society of Endocrinology (ESE), the journal has grown to become one of the most prominent publications in the field of endocrinology, with a global readership and significant academic influence.
Published by Bioscientifica Ltd, EJE offers a platform for the publication of original research articles, reviews, and clinical guidelines. The journal serves as a valuable resource for endocrinologists, clinicians, researchers, and medical professionals who seek the latest advancements in the field of endocrinology.
EJE covers a wide range of topics within endocrinology, including thyroid function, metabolism, diabetes, reproductive health, adrenal disorders, and bone metabolism. The journal is dedicated to publishing both basic and clinical research that enhances the understanding of endocrine diseases and improves the management and treatment of patients.
The editorial board of EJE is composed of leading experts in endocrinology from around the world, ensuring that only high-quality, relevant research is published. The journal uses a rigorous peer-review process to maintain the integrity and quality of its content.
With its hybrid publishing model, EJE offers authors the choice to publish their articles under a subscription-based model or as open access, making it accessible to a wider audience. This flexibility is particularly valuable in promoting collaboration between researchers, healthcare professionals, and policymakers in the global endocrinology community.
Indexed in major academic databases such as PubMed, Scopus, and Web of Science, EJE continues to play a key role in advancing the field of endocrinology. The journal’s high impact factor is a testament to its ongoing contribution to research and education in endocrinology.
For those interested in submitting their research, EJE offers a straightforward online submission process, making it easy for authors to contribute to the journal’s growing body of knowledge. Whether you are a researcher conducting laboratory experiments, a clinician treating endocrine disorders, or a policymaker seeking evidence-based insights, EJE is an indispensable resource in the field of endocrinology.
Recent Research Articles
Latest publications matched automatically by ISSN.
Transcriptomic and proteomic signatures predict in vitro response to mitotane in adrenocortical carcinoma
Charlotte L Vietor, Anand M Iyer, Peter M van Koetsveld, Sigrid M A Swagemakers et al.
2026-09-09 · DOI: 10.1093/ejendo/lvag168Adverse health outcomes across the life course in individuals with six rare bone diseases: a 10-year population-based cohort study
Pascal Gaechter, Christian Meier, Emanuel Christ, Fahim Ebrahimi et al.
2026-09-03 · DOI: 10.1093/ejendo/lvag171Glucocorticoid Replacement Duration After Unilateral Adrenalectomy for Mild Autonomous Cortisol Secretion and Adrenal Cushing Syndrome: A Multicenter Cohort Study
You-Bin Lee, Seung Shin Park, Min Jeong Park, Jeongmin Lee et al.
2026-09-03 · DOI: 10.1093/ejendo/lvag172Long-acting growth hormone: An updated Growth Hormone Research Society consensus statement
Katharina Schilbach, Peter Clayton, Nidhi Agrawal, Mai C Arlien-Søborg et al.
2026-09-01 · DOI: 10.1093/ejendo/lvag167Association between antibiotic use and Graves’ disease: A cohort study
Yaejin Son, Sun Jae Park, Ju Hyun Kang, Jina Chung et al.
2026-08-31 · DOI: 10.1093/ejendo/lvag170Metyrapone-associated improvements in health-related quality of life in Cushing's syndrome
Emese Mezôsi, Lynnette K Nieman, Carla Scaroni, Marco Boscaro et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag164Immune signatures associated with human adrenocortical hypertension
Riccardo Scarpa, Maria Piazza, Brasilina Caroccia, Samuela Carraro et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag126Estradiol and other sex hormone dynamics in menstrual migraine: pathway analysis of hormones in a case-control follow-up study
Britt W H van der Arend, Iris E Verhagen, Daphne S van Casteren, Jelle J Goeman et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag138Macrolide-Induced Aldosterone Suppression as a Functional Marker of KCNJ5-Mutated Aldosterone-Producing Adenoma: A Proof-of-Concept Clinical and Experimental Study (MAPA Study)
Gian Paolo Rossi, Brasilina Caroccia, Alessandro Bressan, Clement Byiringiro et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag161Low-frequency CDKN1B variants in pituitary testing: a diagnostic pitfall
Albain Chansavang, Chloé Friedrich, Emmanuelle Kuhn, Aurélie Toussaint et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag165Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy
Erika Messina, Martina Romanisio, Antonio Gigante, Cinzia Parola et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag163Sex differences in endocrine health: insights from the EUWIN community
Daniela Esposito, Anastasia Athanasoulia-Kaspar, Trine Elisabeth Finnes, Eugenia Vlachou et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag166Burning questions in endocrinology: navigating the space between evidence and practice
Felix Beuschlein, Irina Bancos
2026-08-28 · DOI: 10.1093/ejendo/lvag162Biochemical control in young women with congenital adrenal hyperplasia taking oral contraceptives: a prospective observational study
Chrysanthi Kouri, Grit Sommer, Fernanda Cavalieri Costa, Mirela Costa de Miranda et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag160The Link Between Acromegaly, Liver Morphology, and MASLD: A Large Cohort Analysis
Polat Ercan, Busra Firlatan Yazgan, Suleyman Nahit Sendur, Selcuk Dagdelen et al.
2026-08-19 · DOI: 10.1093/ejendo/lvag159SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalization, and mortality
Jingya Wang, Jennifer Cooper, Eleanor Hathaway, Megha Singh et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag156Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas
Emanuela Esposito, Emma Nozza, Anna Maria Barbieri, Luca Bosoni et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag155Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial
A Tabarin, S Espiard, T Deutschbein, L Amar et al.
2026-08-28 · DOI: 10.1093/ejendo/lvag142DB16 Long-Term Mortality and Cardiorenal Outcomes Following Hyperosmolar Hyperglycaemic State: A Matched Cohort Study of 1.9 Million People with Diabetes in England
A Manta, R Thayakaran, N J Adderley, K Dhatariya et al.
2026-08-27 · DOI: 10.1093/ejendo/lvag128.020TR07 Preoperative calcitonin-to-CEA ratio as a predictor of lymph node metastasis in medullary thyroid carcinoma: a single-center retrospective study
R Çankaya, E Üçgül, M B Görgülü, B Menekşe et al.
2026-08-27 · DOI: 10.1093/ejendo/lvag128.080Reviews
Community Reviews
Version History
April 16, 2025 at 10:51 am
March 29, 2025